Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 9, 2021

Total Value ($000): $303,302 (100.0% shares, 0.0% debt)

Holdings (9)

— KARUNA THERAPEUTICS INC 36.3%

Value ($000) $110,057 Shares 1,083,344 Est. Cost $101.59 Unrealized —

PCVX VAXCYTE INC 19.5%

Value ($000) $59,064 Shares 2,222,970 Est. Cost $37.18 Unrealized 0.0%

— AKOUOS INC 11.7%

Value ($000) $35,577 Shares 1,794,088 Est. Cost $19.83 Unrealized —

— INOZYME PHARMA INC 10.8%

Value ($000) $32,841 Shares 1,591,154 Est. Cost $20.64 Unrealized —

— ALIGOS THERAPEUTICS INC 8.0%

Value ($000) $24,237 Shares 876,548 Est. Cost $27.65 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 6.2%

Value ($000) $18,895 Shares 671,716 Est. Cost $24.49 Unrealized 0.0%

— FUSION PHARMACEUTICALS INC 6.2%

Value ($000) $18,781 Shares 1,598,379 Est. Cost $11.75 Unrealized —

— ENTASIS THERAPEUTICS HLDGS I 1.0%

Value ($000) $2,915 Shares 1,180,178 Est. Cost $2.47 Unrealized —

— ITERUM THERAPEUTICS PLC 0.3%

Value ($000) $935 Shares 945,085 Est. Cost $0.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	1,083,344	$110,057	36.3%	$101.59	—	COM	48576A100
PCVX	VAXCYTE INC	2,222,970	$59,064	19.5%	$37.18	0.0%	COM	92243G108
—	AKOUOS INC	1,794,088	$35,577	11.7%	$19.83	—	COM	00973J101
—	INOZYME PHARMA INC	1,591,154	$32,841	10.8%	$20.64	—	COM	45790W108
—	ALIGOS THERAPEUTICS INC	876,548	$24,237	8.0%	$27.65	—	COM	01626L105
ARQT	ARCUTIS BIOTHERAPEUTICS INC	671,716	$18,895	6.2%	$24.49	0.0%	COM	03969K108
—	FUSION PHARMACEUTICALS INC	1,598,379	$18,781	6.2%	$11.75	—	COM	36118A100
—	ENTASIS THERAPEUTICS HLDGS I	1,180,178	$2,915	1.0%	$2.47	—	COM	293614103
—	ITERUM THERAPEUTICS PLC	945,085	$935	0.3%	$0.99	—	SHS	G6333L101